While many in the U.S. and the West shelter in place hoping that warmer spring weather will slow the spread of the Wuhan coronavirus, China is planning its own Spring Offensive.
China sees an opportunity to exploit the fear and carnage of the outbreak to strengthen its hold over global supply chains — and the medical-equipment and pharmaceuticals sector is the next industry in China’s sights.
It’s a bold move, but a deeper look reveals the fundamental weakness in China’s dominant position in global logistics and points to two strategic opportunities for the U.S. The first is to bring supply chains for …
This article appears as “Restoring America’s Commercial Sea Power ” in the April 20, 2020, print edition of National Review.
Something to Consider
If you enjoyed this article, we have a proposition for you: Join NRPLUS. Members get all of our content (including the magazine), no paywalls or content meters, an advertising-minimal experience, and unique access to our writers and editors (through conference calls, social media groups, and more). And importantly, NRPLUS members help keep NR going.